Skip to content

Tom Depovere

Active
Private limited company·Activiteiten van huisartspraktijken· 5 yrs active
Jan De Trochstraat 73 ·1703 Dilbeek, Belgium
KBO/BCE: BE 0771.803.561
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Tom Depovere is 0.2% (very low). The 2024 annual accounts show equity of €551k and a net result of €193k. Equity is growing by ~43.5% per year across the filed fiscal years. Its solvency ranks better than 78% of 6584 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 78% of 6584 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 18 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-04-2025, 94 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 28-04-2025 94 d early 2025-00077612
31-12-2023 31-07-2024 30-04-2024 92 d early 2024-00078701
31-12-2022 31-07-2023 15-06-2023 46 d early 2023-00128230

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€193k+63.9%
Working capital€573k+58.6%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 28-04-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200k€300kOperating result 2022: €288k€288kNet result 2022: €220k€220kOperating result 2023: €152k€152kNet result 2023: €118k€118kOperating result 2024: €252k€252kNet result 2024: €193k€193k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~43.5%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€250k€500k€750k€1.00M2025: €706k (€662k - €750k)2026: €862k (€818k - €906k)2027: €1.02M (€973k - €1.06M)2022: €240k2023: €358k2024: €551k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 85.0% 66.7%
better than 78% of 6584 sector peers
Net result €193k €46k
better than 93% of 6578 sector peers
Equity €551k €79k
better than 95% of 6584 sector peers
Gross operating margin €300k €78k
better than 93% of 6586 sector peers
Staff costs €26k €21k
higher than 56% of 1212 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P78
2022: P57 · n=36852023: P63 · n=53472024: P78 · n=65842022 2024
Improving position over 2022-2024 · n=3685-6584
Net result P93
2022: P95 · n=36832023: P87 · n=53462024: P93 · n=65782022 2024
Stable position over 2022-2024 · n=3683-6578
Equity P95
2022: P88 · n=36852023: P92 · n=53492024: P95 · n=65842022 2024
Stable position over 2022-2024 · n=3685-6584
Gross operating margin P93
2022: P95 · n=36812023: P88 · n=53432024: P93 · n=65862022 2024
Stable position over 2022-2024 · n=3681-6586
Describes the position versus peers, not a forecast.
EBITDA
€273k
+61.9% 22-24
Net profit
€193k
+63.9% 22-24
Cash flow
€214k
+59.2% 22-24
Total assets
€648k
+35.0% 22-24
Equity
€551k
+54.0% 22-24
Working capital
€573k
+58.6% 22-24
Staff costs
€26k
+23.1% 22-24
Income taxes
€59k
+78.3% 22-24
Show 10 other metrics
Debt
€97k
-20.7% 22-24
Debt ≤ 1y
€22k
-53.5% 22-24
Debt > 1y
€75k
0.0% 22-24
Current ratio
27.14
+213.5% 22-24
Quick ratio
27.14
+213.5% 22-24
Solvency
85.0%
+14.1% 22-24
Debt / equity
0.18
-48.5% 22-24
ROE
35.1%
+6.4% 22-24
ROA
29.8%
+21.4% 22-24
Interest coverage
285.57
+153.5% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€273k
Net profit€193k
Cash flow€214k
Staff costs€26k
Income taxes€59k
Dividends-
Total assets€648k
Equity€551k
Debt€97k
of which ≤ 1y€22k
of which > 1y€75k
Working capital€573k
Employees (FTE)-
Ratios (computed)
2024
Current ratio27.14
Quick ratio27.14
Working capital ratio88.4%
Solvency85.0%
Debt / equity0.18
Long-term debt ratio0.14
Interest coverage285.57
Gross margin-
Net margin-
ROA29.8%
ROE35.1%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€648k
Fixed assets 21/28€53k
Tangible fixed assets 22/27€53k
Current assets 29/58€595k
Amounts receivable within one year 40/41€10k
Investments 50/53€335k
Cash & bank 54/58€244k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€648k
Equity 10/15€551k
Contributions / capital 10/11€20k
Reserves 13€531k
Amounts payable 17/49€97k
Amounts payable after one year 17€75k
Amounts payable within one year 42/48€22k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€300k
Operating result 9901€252k
Financial income 75€352
Financial charges 65€958
Result before taxes 9903€252k
Income taxes 67/77€59k
Net result for the period 9904€193k
Result to be appropriated 9905€193k
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Jan De Trochstraat 731703 Dilbeek

Establishment units

1 location
Tom Depovere
Jan De Trochstraat 73, 1703 DilbeekActiviteiten van medisch specialisten
since 20212.321.337.682
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,184 m²
Buildings1
Building footprint135 m²
Volume (LiDAR)687 m³
Tallest building8.0 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23070D0210/00B000 Flanders 1,184 m² 1 · 135 m² 8.0 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Financial profile

5 of 5 axes measured
Health100Profitability100Solvency100Growth52Stability94
89 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 52
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Huisartspraktijken86210Activiteiten van huisartspraktijken86210Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL Tom Depovere
Registered office
Jan De Trochstraat 73
1703 Dilbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.